183 related articles for article (PubMed ID: 8238052)
1. Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals.
Segal R; Russell WL; Oh T; Ben-Joseph R
Am J Hosp Pharm; 1993 Oct; 50(10):2077-81. PubMed ID: 8238052
[TBL] [Abstract][Full Text] [Related]
2. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine.
Oh T; Franko TG
Am J Hosp Pharm; 1990 Jul; 47(7):1547-51. PubMed ID: 2114789
[TBL] [Abstract][Full Text] [Related]
3. Risk for adverse events among patients receiving intravenous histamine2-receptor antagonists.
Ben-Joseph R; Segal R; Russell WL
Ann Pharmacother; 1993 Dec; 27(12):1532-7. PubMed ID: 8305790
[TBL] [Abstract][Full Text] [Related]
4. Clinical review of histamine2 receptor antagonists.
Lipsy RJ; Fennerty B; Fagan TC
Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
[TBL] [Abstract][Full Text] [Related]
5. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
Segal R; Oh T; Ben-Joseph R; Russell WL
Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia.
Slichenmyer WJ; Donehower RC; Chen TL; Bowling MK; McGuire WP; Rowinsky EK
Cancer Chemother Pharmacol; 1995; 36(3):227-32. PubMed ID: 7781143
[TBL] [Abstract][Full Text] [Related]
7. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
9. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
Kedziora-Kornatowska K; Tkaczewski W; Blaszczyk J; Buczynski A; Chojnacki J; Kedziora J
Hepatogastroenterology; 1998; 45(19):276-80. PubMed ID: 9496526
[TBL] [Abstract][Full Text] [Related]
10. Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital.
Dannenhoffer MA; Slaughter RL; Hunt SN
Am J Hosp Pharm; 1989 Aug; 46(8):1570-5. PubMed ID: 2773962
[TBL] [Abstract][Full Text] [Related]
11. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
[TBL] [Abstract][Full Text] [Related]
12. The use of intravenous H2-receptor antagonists in a tertiary care hospital.
Dettmer RM; Riley TH; Byfield F; Green PH
Am J Gastroenterol; 1999 Dec; 94(12):3473-7. PubMed ID: 10606306
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist intervention program focused on i.v. ranitidine therapy.
Santora J; Kitrenos JG; Green ER
Am J Hosp Pharm; 1990 Jun; 47(6):1346-9. PubMed ID: 2368729
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the hemodynamic effects of oral cimetidine, ranitidine, and famotidine as determined by echocardiography.
Welage LS; Dunn-Kucharski VA; Berardi RR; Shea MJ; Dechert RE; Bleske BE
Pharmacotherapy; 1995; 15(2):158-63. PubMed ID: 7624262
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral H2-receptor antagonists on left ventricular systolic function and exercise capacity in patients with chronic stable heart failure.
Lucas BD; Williams MA; Mohiuddin SM; LaMadrid LJ; Schroeder LJ; Hilleman DE
Pharmacotherapy; 1998; 18(4):824-30. PubMed ID: 9692655
[TBL] [Abstract][Full Text] [Related]
17. Gastroesophageal reflux and histamine2 antagonists.
Bell SG
Neonatal Netw; 2003; 22(2):53-7. PubMed ID: 12696725
[No Abstract] [Full Text] [Related]
18. Hemodynamic effects of H2-receptor antagonists.
Iberti TJ
DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
[TBL] [Abstract][Full Text] [Related]
19. Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
Kumana CR; Ching TY; Cheung E; Kong Y; Kou M; Chan CK; Chu KM; Seto WH; Lam SK
Clin Pharmacol Ther; 1998 Nov; 64(5):569-74. PubMed ID: 9834050
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of H2-receptor antagonists: current status of famotidine.
Levine JB
J Int Med Res; 1989; 17 Suppl 1():48A-53A. PubMed ID: 2566543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]